Singapore Maker Of Pain Patch Said In Noncompliance By U.S. FDA
This article was originally published in PharmAsia News
Executive Summary
Singapore's Haw Par has been notified by U.S. FDA that its painkiller patch Tiger Balm contains a pharmaceutical that must be tested and approved before marketing